Gohealth Inc expected to post a loss of $2.47 a share - Earnings Preview

GoHealth

06/08/2024 18:52

* Gohealth Inc  GOCO.OQ   GOCO.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 8 for the
period ending June 30 2024
    * The Chicago Illinois-based  company is expected to report
a
0.7% decrease in revenue to $141.793 million from $142.78
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Gohealth Inc is for a
loss of
$2.47 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gohealth
Inc is
$20.00​, above​ its last closing price of $12.44. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.96       -0.95      -1.04     Missed  -9.1
 Jan. 1 2024   2.74        2.73       -0.22     Missed  -108.1
 Sep. 30 2023  -2.90       -2.90      -2.61     Beat    10​
 Jun. 30 2023  -2.33       -2.92      -3.27     Missed  -12.1
 ​​Mar.        -1.93       -1.96      -1.12     Beat    42.8
 31 2023                                                
 Dec. 31 2022  1.49        1.33       -7.00     Missed  -626.4
                                                        ​
 Sep. 30 2022  -4.24       -4.30      -3.30     Beat    23.3
 Jun. 30 2022  -3.75       -3.38      -2.25     Beat    33.4
 This summary was machine generated August 6 at 17:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)